About
A clinical oncologist and entrepreneur, co-founder and board member of BioNTech, and a leading expert in translational tumour immunology. He founded the cancer immunotherapy association CIMT and was named European Manager of the Year in 2021.
Experience
- Momentous Therapeutics LtdDirectorcurrent2023 — present
- Medizinische Universität WienMember Supervisory Board and Research Translationcurrent2022 — present
- BioNTech SECo-Founder / Board Member2008 — 2024
- TRON-MainzFounder / Board Member2009 — 2020
- Ganymed PharmaceuticalsCofounder and Deputy Chairman Supervisory Board2001 — 2016
- Universitätsmedizin MainzChairman Department Hematology & Oncology1990 — 2009
Education
- Medizinische Universität Innsbruck1968, MD
Skills & more
Cancer Immunotherapy · Oncology · Biotechnology · mRNA Technologies · Drug Development · Translational Medicine · Entrepreneurship · Mentoring
From Christoph's professional profile.
Colleagues at Onsight Ventures
Andrea Waldhart
Investor Relations & Fund Management at Onsight Ventures
Dennis Weiß
Investment Manager at Onsight Ventures
Dr. Hermann Hauser
Advisory Board at Onsight Ventures
Gabriel Dielacher
Advisory Board at Onsight Ventures
Hermann Hauser
Co-Founder and Venture Partner at Amadeus Capital Partners
Jasmin Güngör
General Partner at Onsight Ventures
Kathrin Vallant
Back Office at Onsight Ventures
Klaus Grössinger
General Partner at Onsight Ventures
Frequently asked questions
- Where does Christoph Huber work?
- Christoph Huber is Advisory Board at Onsight Ventures.
